 


Accelerated healing. Reduced pain.


More than 80% of patients affected with a chronic wound reported pain at all times3


.


Results from NATROX®


O2


Patients


71% greater healing rates than those receiving standard of care alone1


76% experienced substantial pain relief2


69% were able to stop using wound-related opioids2


Learn more by visiting our website or sign up for our EWMA 2025 Symposium in Barcelona 26-28 March!


VisV sit our web te


ou websiit NATROX® is a registered trade mark of Inotec AMD Limited in EU, China, USA & UK


1. Serena TE, Bullock NM, Cole W, et al. (2021) Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled trial. J Wound Care 30(Suppl.5): S7-14. 2. Jebril W, Nowak M, Palin L, et al. (2022) Topical oxygen treatment relieves pain from hard-to-heal leg ulcers and improves healing: a case series. J Wound Care 2022;31(1):4-11. 3. Woo K, Sibbald G, Fogh K, et al. (2008) Assessment and management of persistent (chronic) and total wound pain. Int Wound J, 5(2):205-15.


ViisV siit us EW


s at EWMA


Unit 7340 | Building 7300 Cambridge Research Park | Beach Drive | Waterbeach | Cambridge | England | CB25 9PD


AD2_PPC_02/25


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45